ACE-inhibitors	Angiotensin Converting Enzyme inhibitors
ARBs	Angiotensin Receptor Blockers
AF	Atrial Fibrillation
AFFIRM	Atrial Fibrillation Follow-up Investigation of Rhythm Management
AFL	Atrial Flutter
ARNI	Angiotensin Receptor/Neprilysin Inhibitors
AT	Atrial Tachycardia
AVRT	Atrio-Ventricular reentrant (or reciprocating) tachycardia
BRS	Baroreflex Sensitivity
CHARM	Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity
COR	Class of Recommendation
DCM	Dilated Cardiomyopathy
ESC	European Society of Cardiology
HF	Heart Failure
HFrEF	Heart Failure Reduced Ejection Fraction
HFmEF	Heart Failure mid reduction Ejection Fraction
HFpEF	Heart Failure Preserved Ejection Fraction
ICD	Implantable Cardioverter Defibrillator
I-PRESERVE	Irbesartan in Heart Failure with Preserved Ejection Fraction Study
MADIT II	Multicenter Automatic Defibrillator Implantation Trial Investigator II
MRAs	Mineral Receptor Antagonists
MTWA	Microvolt T-wave alternans
NYHA	New York Heart Association
NSVT	Non Sustained Ventricular Tachycardia
PABA-CHF	Pulmonary Vein Antrum Isolation vs. AV Node Ablation With Biventricular Pacing for Treatment of Atrial Fibrillation in Patients with Congestive Heart Failure
PARAGON-HF	Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients with Preserved Ejection Fraction
PVCs	Premature Ventricular Complexes
RACE II	The Rate Control Efficacy in Permanent Atrial Fibrillation: a Comparison between Lenient versus Strict Rate Control II
SR	Sinus Rhythm
SVAs	Supraventricular arrhythmias
SVT	Sustained Ventricular Tachycardia
SCD	Sudden Cardiac Death
TOPCAT	Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist
Vas	Ventricular Arrhythmias
VT	Ventricular Tachycardia
VF	Ventricular Fibrillation